Raimundo Goncalves de Oliveira Junior, lecturer in pharmacognosy (chemistry of natural substances) and Erasmus educational coordinator for the Pharmacy Department at Université Paris Cité, was welcomed on November 19, 2024 at the headquarters of the Universidade Federal do Vale do São Francisco (UNIVASF) to sign the academic mobility agreement between the two establishments and to discuss the various international mobility schemes for researchers and students.
From left to right: Pr Jackson Almeida (Brazilian coordinator of the agreement), Pr Telio Nobre Leite (president of UNIVASF), Dr Raimundo Gonçalves de Oliveira Junior (French coordinator of the agreement, Erasmus pedagogical coordinator for the Pharmacy Department), Pr Lucia Marisy de Oliveira (vice-president of UNIVASF and IR coordinator), and Bruno Cezar Silva (IR assessor, UNIVASF)
Active cooperation between the Pharmacy Department and Brazil
Raimundo Goncalves de Oliveira Junior’s research and projects focus on natural products (plants, algae for use in oncology) and Brazilian endemic plants. He works within UMR 8038 CNRS CiTCoM: “Therapeutic targets and drug design”, alongside Raphaël GROUGNET, lecturer in pharmacognosy at Université Paris Cité and also involved in exchanges with Brazil.
The Franco-Brazilian virtual network for natural products (FB2NP)
Université Paris Cité is a member of the Franco-Brazilian Virtual Network of Natural Products (FB2NP), founded in 2019 by the Federal University of the São Francisco Valley (UNIVASF) and the University of La Rochelle. Raimundo Goncalves de Oliveira Junior is the young researcher coordinator of this dynamic network, which brings together over forty French and Brazilian laboratories.
As part of this project, Université Paris Cité wished to formalize the strong links it maintains with four universities in the network: Universidade Federal Fluminense (UFF), Universidade Federal de la Valle de São Francisco (UNIVASF), Universidade Federal de Sergipe (UFS) and Universidade Federal do Rio Grande do Norte (UFRN), with whom it has collaborated on over twenty publications.
First agreement signed with the Federal University of the São Francisco Valley
The signing of the first academic mobility agreement with the Federal University of the São Francisco Valley marks the strengthening of relations between the Pharmacy Department and Brazil.
This five-year agreement formalizes the collaborations undertaken since 2015, which have led to the supervision of master’s and doctoral students, as well as the publication of ten scientific articles between 2020 and 2023.
Raimundo Goncalves de Oliveira Junior was received in November by UNIVASF’s president, Prof. Telio Nobre Leite, its vice-president and head of international relations, Prof. Lucia Marisy de Oliveira, as well as the agreement’s pedagogical coordinator, Prof. Jackson Almeida, and international relations assessor, Bruno Cezar Silva, to celebrate the signing of the agreement and discuss the various international mobility schemes for researchers and students from both establishments. A delegation from UNIVASF is expected at the Pharmacy Department in April 2025 for the symbolic signing of the agreement with Pr Jean-Louis Beaudeux, director of the UFR, and members of the pharmacy international relations office.
During his visit to Brazil and UNIVASF in November, Raimundo Goncalves de Oliveira Junior gave a lecture at the tenth SEFARM (Semana Farmacêutica do Vale do São Francisco) conference, organized to commemorate the 15th anniversary of the establishment of the Faculty of Pharmacy in the region.
À lire aussi
[Keynote Recherche] Guillaume Canaud : La médecine translationnelle au service des maladies rares : de la découverte au traitement
From a single patient to an US FDA approved drug – the story of a drug repositioning for a rare disease. Le Pr Guillaume Canaud est néphrologue à l'Hôpital Necker – Enfants Malades, professeur à l'Université Paris Cité et chercheur à l'Inserm. Ayant plus de 100...
Leucémie aiguë myéloïde : une nouvelle piste pour surmonter la résistance aux traitements
Les équipes d'Alexandre Puissant et Camille Lobry (IHU Institut de la Leucémie, Université Paris Cité / Inserm / AP-HP), basées à l'Hôpital Saint-Louis, ont découvert un réseau moléculaire responsable de la résistance aux traitements dans la leucémie aiguë myéloïde....
Retour sur le Grand Debunk de la Santé : la Faculté de Santé décrypte les fake news
Le 25 juin 2026, la Faculté de Santé de l’Université Paris Cité a vibré au rythme de la première édition du « Grand Debunk de la Santé ». Malgré une canicule historique à 40 °C, le public a répondu présent dans un amphithéâtre adapté pour l'occasion. En partenariat...
Le Pr Nathan Peiffer-Smadja lauréat du palmarès TIME France Health 2026
Le Pr Nathan Peiffer-Smadja, enseignant-chercheur à la Faculté de Santé de l’Université Paris Cité et PU-PH à l’Hôpital Bichat – Claude Bernard (AP-HP), a été distingué avec 19 autres lauréates et lauréats de la première édition du palmarès national TIME France...